Policy & Advocacy

Hear from AlzInColor and other brain health advocates and leaders at CBCF’s 55th Annual Legislative Conference as they discuss why the Alzheimer’s Screening and Prevention (ASAP) Act matters for early detection, access to blood-based biomarker testing, and communities disproportionately affected by Alzheimer’s disease.

Published by Solving Alzheimer’s, an AlzInColor community partner, Robert Reid recounts the years his wife Kim experienced changes before receiving an early-onset Alzheimer’s diagnosis. Drawing from their family’s experience, Robert highlights the challenges that can delay a diagnosis and the need for greater awareness and earlier detection, while calling for passage of the bipartisan ASAP Act.

In recognition of Hispanic Heritage Month, AlzInColor speaks with Dr. Elena Rios, President of the National Hispanic Health Foundation (NHHF), about the importance of early Alzheimer’s detection, advances in blood-based biomarker testing, and the bipartisan Alzheimer’s Screening and Prevention (ASAP) Act. Dr. Rios challenges misconceptions about Alzheimer’s and emphasizes how earlier detection can give individuals and families more time to explore treatment options, plan for care, and take action.

In her RealClear Health op-ed, Dr. Elena Rios, President of the National Hispanic Health Foundation and AlzInColor supporting partner, shares her family’s experience with Alzheimer’s and the disparities affecting Latino communities. She emphasizes the importance of early detection, culturally responsive care, caregiver support, and advancing the bipartisan ASAP and AADAPT Acts to improve access to screening and provider training.